Related Experiment Videos
Potential for antimicrobial resistance in Chlamydia pneumoniae
1Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, WA 98195, USA. wes@u.washington.edu
Abstract:
Antimicrobial resistance has not yet been described in wild type Chlamydia pneumoniae isolates, nor has selective emergence of resistance in the laboratory after exposure to subinhibitory concentrations of antibiotic. However, few clinical isolates have been tested for resistance, especially strains with resistance phenotypes (i.e., those associated with clinical failure or persistence). More widespread testing of such strains is needed. Further understanding of antimicrobial resistance in chlamydiae would benefit from the development of standardized methods. Further, more physiologic testing methodologies that more closely mimic the chronic intracellular infection usually being treated in vivo would be of value. Animal models demonstrate persistence of C. pneumoniae after antimicrobial therapy and could be used to better define the clinical correlates of in vitro testing.
Insights
Antimicrobial resistance is not yet documented in wild type Chlamydia pneumoniae. Further research is needed to understand resistance in clinical strains and develop standardized, physiologic testing methods.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Antimicrobial resistance (AMR) in Chlamydia pneumoniae is not well-characterized.
- Limited testing of clinical isolates, particularly those with resistance phenotypes linked to treatment failure, hinders understanding.
- Existing in vitro methods may not fully replicate the chronic intracellular infection observed in vivo.
Purpose of the Study:
- To highlight the need for expanded testing of clinical Chlamydia pneumoniae isolates for antimicrobial resistance.
- To emphasize the necessity for standardized and more physiologically relevant testing methodologies.
- To explore the utility of animal models in understanding C. pneumoniae persistence post-antimicrobial therapy.
Main Methods:
- Review of existing literature on Chlamydia pneumoniae antimicrobial resistance.
- Discussion of limitations in current resistance testing approaches.
- Consideration of animal models for in vivo validation.
Main Results:
- No documented antimicrobial resistance in wild-type Chlamydia pneumoniae isolates.
- Lack of widespread testing for resistance in clinical strains, especially those associated with treatment failure.
- Animal models show C. pneumoniae persistence after therapy, suggesting limitations of in vitro data.
Conclusions:
- Widespread testing of clinical Chlamydia pneumoniae isolates for resistance is crucial.
- Development of standardized and physiologically relevant testing methods is required.
- Animal models can provide valuable insights into in vivo resistance and persistence.